|
Lapatinib
I had a consult with Dr. Pegram at UCLA yesterday, to discuss Lapatinib as a possible treatment for me.
He indicated that he expected it to be FDA approved on March 13th, and that it would be available shortly after that locally. He recommended that I add the Lapatinib to Herceptin.
In his opinion, the major benefit with brain mets, was in preventing new ones from developing. The success rate in reducing the size of existing lesions was in the single digits.
It may be a promising new treatment era in the near future. Herceptin alone has kept me fairly steady in the liver and bone mets for 2 years now, perhaps the time is coming when Lapatinib/Herceptin will do the same for our brain mets issues as well.
As always, Dr. Pegram was reassuring and informative and I value being able to consult with him.
|
Threaded Mode